Apollo Hospitals Gains 5.34%: 6 Key Factors Driving This Week’s Momentum

Feb 14 2026 05:11 PM IST
share
Share Via
Apollo Hospitals Enterprise Ltd. delivered a strong weekly performance, rising 5.34% from Rs.7,155.80 to Rs.7,538.25 between 9 and 13 February 2026, significantly outperforming the Sensex which declined 0.54% over the same period. The stock demonstrated resilience amid mixed market signals, supported by robust intraday gains, active derivatives trading, and sustained institutional interest, despite a recent downgrade in its mojo rating to Hold.

Key Events This Week

9 Feb: Stock opens week at Rs.7,211.30 with 0.78% gain

10 Feb: Q3 FY26 results reveal strong profit growth amid valuation concerns

11 Feb: Intraday high of Rs.7,570 with 5.68% surge and record derivatives activity

12 Feb: Moderate gain of 0.44% despite Sensex decline

13 Feb: Week closes at Rs.7,538.25, up 0.01% on the day

Week Open
Rs.7,155.80
Week Close
Rs.7,538.25
+5.34%
Week High
Rs.7,570
Sensex Change
-0.54%

9 February 2026: Week Opens with Positive Momentum

Apollo Hospitals began the week on a positive note, closing at Rs.7,211.30, up 0.78% from the previous Friday’s close of Rs.7,155.80. This gain was slightly below the Sensex’s 1.04% rise to 37,113.23, indicating a cautious but optimistic start. The volume of 10,994 shares reflected steady investor interest as the stock positioned itself for the week ahead.

10 February 2026: Strong Q3 Profit Growth Counters Valuation Concerns

The company reported robust profit growth for Q3 FY26, which was well received by the market despite lingering valuation concerns. The stock edged up 0.12% to Rs.7,220.00, outperforming the Sensex’s modest 0.25% gain. However, delivery volumes declined by 43.86% compared to the five-day average, suggesting some profit-booking or cautious positioning by long-term holders. The mojo rating downgrade to Hold, effective from 9 January, likely tempered enthusiasm but did not deter active trading.

11 February 2026: Intraday High and Record Derivatives Activity

Apollo Hospitals demonstrated remarkable strength on 11 February, surging 3.93% to close at Rs.7,503.95, with an intraday high of Rs.7,570 representing a 5.68% gain from the previous close. The stock outperformed the Sensex, which rose a mere 0.13% that day. This rally was supported by a significant increase in trading volume, reaching 91,153 shares, and a total traded value of ₹48,490.76 lakhs, placing it among the most actively traded stocks by value.

Derivatives activity was particularly notable, with open interest rising 13.2% to 61,666 contracts and a total notional value exceeding ₹89,620.76 lakhs. Call options at strike prices near the current market value saw heavy volumes, signalling bullish sentiment ahead of the 24 February expiry. Simultaneously, put options also recorded substantial activity, indicating hedging or cautious positioning by some investors. The stock maintained its position above all key moving averages, reinforcing its technical strength.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

12 February 2026: Modest Gains Amid Market Weakness

Despite the Sensex declining 0.56% to 37,049.40, Apollo Hospitals managed to add 0.44% to close at Rs.7,537.15. The stock’s ability to hold ground amid broader market weakness highlights its defensive qualities within the healthcare sector. Trading volume moderated to 11,342 shares, reflecting a more measured approach by investors following the previous day’s surge.

13 February 2026: Week Closes with Stability

The stock closed the week at Rs.7,538.25, up a marginal 0.01% on the day, while the Sensex fell 1.40% to 36,532.48. Volume surged to 68,781 shares, indicating renewed interest as the week ended. The stock’s 5.34% weekly gain stands in stark contrast to the Sensex’s 0.54% decline, underscoring Apollo Hospitals’ relative strength and sector leadership.

Holding Apollo Hospitals Enterprise Ltd. from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Daily Price Comparison: Apollo Hospitals vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-02-09 Rs.7,211.30 +0.78% 37,113.23 +1.04%
2026-02-10 Rs.7,220.00 +0.12% 37,207.34 +0.25%
2026-02-11 Rs.7,503.95 +3.93% 37,256.72 +0.13%
2026-02-12 Rs.7,537.15 +0.44% 37,049.40 -0.56%
2026-02-13 Rs.7,538.25 +0.01% 36,532.48 -1.40%

Key Takeaways

Outperformance and Technical Strength: Apollo Hospitals outpaced the Sensex by nearly 6 percentage points over the week, supported by a seven-day winning streak and trading above all major moving averages. The intraday high of Rs.7,570 on 11 February marked a significant technical milestone.

Robust Derivatives Activity: The surge in open interest and heavy volumes in both call and put options ahead of the 24 February expiry reflect a complex market positioning. While call option volumes suggest bullish expectations, the substantial put activity indicates hedging or cautious sentiment among some investors.

Institutional Interest and Liquidity: High traded values and liquidity support sizeable institutional trades, although delivery volumes have moderated, hinting at a mix of short-term trading and profit-booking.

Mojo Rating and Valuation Concerns: The downgrade to a Hold rating signals analyst caution, likely due to valuation and sector headwinds. Nonetheless, the stock’s price action and market participation demonstrate continued investor confidence in its fundamentals.

Sectoral Context: The hospital and healthcare sector’s recent gains underpin Apollo Hospitals’ performance, benefiting from structural growth drivers despite regulatory and cost pressures.

Conclusion

Apollo Hospitals Enterprise Ltd. exhibited a strong and resilient performance during the week ending 13 February 2026, gaining 5.34% and significantly outperforming the Sensex’s decline. The stock’s technical momentum, robust derivatives market activity, and sustained institutional interest underscore its prominence within the healthcare sector. However, mixed signals from heavy put option volumes and a Hold mojo rating advise a balanced approach. Investors should monitor price action around key option strike prices and sector developments closely as the February expiry approaches, while weighing valuation considerations against the company’s solid fundamentals and market leadership.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News